A transoesophagealis echocardiographia szerepe a mitralis mechanikus mübillentyü thrombosis fibrinolytikus kezelésében.

Translated title of the contribution: The role of transesophageal echocardiography in the fibrinolytic treatment of thrombosis on the artificial mitral valve

M. Lengyel, Z. Wladika, J. Borbola, L. Vándor, M. Keltai, P. Dékány

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fibrinolytic treatment of mitral mechanical prosthetic valve thrombosis is still controversial. This treatment can only be justified if the incidence and severity of complications is relatively low compared to the expected success-rate. The purpose of this study was to assess the role of transesophageal echocardiography (TEE) in the selection of patients optimally suitable for fibrinolytic therapy. Five patients are reported in whom multiplane TEE revealed mitral prosthetic valve thrombosis. Two patients presented with valve obstruction, one patient with partial obstruction and earlier embolism, one with recent peripheral embolism and in 1 patient the thrombus was an unexpected finding on routine check-up. The oldest thrombus was first seen 5 months before fibrinolysis. There was no left atrial thrombus in any of patients. The thrombus was dissolved in all cases by Streptokinase given in a 200,000 unit bolus, followed by 100,000 unit per hour within 13-72 hours. The result of fibrinolysis was assessed by transthoracic echo-Doppler exam in 2 cases, by TEE in 2, and by both in 1 patient. Transient ischemic attack occurred in one case as the complication of treatment. In conclusion: the fibrinolytic treatment of mitral prosthetic valve thrombosis based on TEE findings is an effective and safe therapeutic modality.

Original languageHungarian
Pages (from-to)955-960
Number of pages6
JournalOrvosi Hetilap
Volume135
Issue number18
Publication statusPublished - May 1 1994

Fingerprint

Transesophageal Echocardiography
Mitral Valve
Thrombosis
Fibrinolysis
Embolism
Therapeutics
Streptokinase
Thrombolytic Therapy
Transient Ischemic Attack
Patient Selection
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A transoesophagealis echocardiographia szerepe a mitralis mechanikus mübillentyü thrombosis fibrinolytikus kezelésében. / Lengyel, M.; Wladika, Z.; Borbola, J.; Vándor, L.; Keltai, M.; Dékány, P.

In: Orvosi Hetilap, Vol. 135, No. 18, 01.05.1994, p. 955-960.

Research output: Contribution to journalArticle

@article{b1addc0490b44235a4725703e58d6b33,
title = "A transoesophagealis echocardiographia szerepe a mitralis mechanikus m{\"u}billenty{\"u} thrombosis fibrinolytikus kezel{\'e}s{\'e}ben.",
abstract = "Fibrinolytic treatment of mitral mechanical prosthetic valve thrombosis is still controversial. This treatment can only be justified if the incidence and severity of complications is relatively low compared to the expected success-rate. The purpose of this study was to assess the role of transesophageal echocardiography (TEE) in the selection of patients optimally suitable for fibrinolytic therapy. Five patients are reported in whom multiplane TEE revealed mitral prosthetic valve thrombosis. Two patients presented with valve obstruction, one patient with partial obstruction and earlier embolism, one with recent peripheral embolism and in 1 patient the thrombus was an unexpected finding on routine check-up. The oldest thrombus was first seen 5 months before fibrinolysis. There was no left atrial thrombus in any of patients. The thrombus was dissolved in all cases by Streptokinase given in a 200,000 unit bolus, followed by 100,000 unit per hour within 13-72 hours. The result of fibrinolysis was assessed by transthoracic echo-Doppler exam in 2 cases, by TEE in 2, and by both in 1 patient. Transient ischemic attack occurred in one case as the complication of treatment. In conclusion: the fibrinolytic treatment of mitral prosthetic valve thrombosis based on TEE findings is an effective and safe therapeutic modality.",
author = "M. Lengyel and Z. Wladika and J. Borbola and L. V{\'a}ndor and M. Keltai and P. D{\'e}k{\'a}ny",
year = "1994",
month = "5",
day = "1",
language = "Hungarian",
volume = "135",
pages = "955--960",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "18",

}

TY - JOUR

T1 - A transoesophagealis echocardiographia szerepe a mitralis mechanikus mübillentyü thrombosis fibrinolytikus kezelésében.

AU - Lengyel, M.

AU - Wladika, Z.

AU - Borbola, J.

AU - Vándor, L.

AU - Keltai, M.

AU - Dékány, P.

PY - 1994/5/1

Y1 - 1994/5/1

N2 - Fibrinolytic treatment of mitral mechanical prosthetic valve thrombosis is still controversial. This treatment can only be justified if the incidence and severity of complications is relatively low compared to the expected success-rate. The purpose of this study was to assess the role of transesophageal echocardiography (TEE) in the selection of patients optimally suitable for fibrinolytic therapy. Five patients are reported in whom multiplane TEE revealed mitral prosthetic valve thrombosis. Two patients presented with valve obstruction, one patient with partial obstruction and earlier embolism, one with recent peripheral embolism and in 1 patient the thrombus was an unexpected finding on routine check-up. The oldest thrombus was first seen 5 months before fibrinolysis. There was no left atrial thrombus in any of patients. The thrombus was dissolved in all cases by Streptokinase given in a 200,000 unit bolus, followed by 100,000 unit per hour within 13-72 hours. The result of fibrinolysis was assessed by transthoracic echo-Doppler exam in 2 cases, by TEE in 2, and by both in 1 patient. Transient ischemic attack occurred in one case as the complication of treatment. In conclusion: the fibrinolytic treatment of mitral prosthetic valve thrombosis based on TEE findings is an effective and safe therapeutic modality.

AB - Fibrinolytic treatment of mitral mechanical prosthetic valve thrombosis is still controversial. This treatment can only be justified if the incidence and severity of complications is relatively low compared to the expected success-rate. The purpose of this study was to assess the role of transesophageal echocardiography (TEE) in the selection of patients optimally suitable for fibrinolytic therapy. Five patients are reported in whom multiplane TEE revealed mitral prosthetic valve thrombosis. Two patients presented with valve obstruction, one patient with partial obstruction and earlier embolism, one with recent peripheral embolism and in 1 patient the thrombus was an unexpected finding on routine check-up. The oldest thrombus was first seen 5 months before fibrinolysis. There was no left atrial thrombus in any of patients. The thrombus was dissolved in all cases by Streptokinase given in a 200,000 unit bolus, followed by 100,000 unit per hour within 13-72 hours. The result of fibrinolysis was assessed by transthoracic echo-Doppler exam in 2 cases, by TEE in 2, and by both in 1 patient. Transient ischemic attack occurred in one case as the complication of treatment. In conclusion: the fibrinolytic treatment of mitral prosthetic valve thrombosis based on TEE findings is an effective and safe therapeutic modality.

UR - http://www.scopus.com/inward/record.url?scp=0028437149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028437149&partnerID=8YFLogxK

M3 - Article

VL - 135

SP - 955

EP - 960

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 18

ER -